ASCP MB common mistakes
ASCP MB · Understand the traps and how to avoid them.
Calculates primer or probe melting temperature with the Wallace rule (2[A+T] + 4[G+C]) and then sets the thermal cycling annealing temperature from that number for a 22–30 base qPCR primer pair.
The Wallace rule is taught early as a fast pen-and-paper estimate and is only valid for very short oligomers; candidates carry it forward into assay design questions without adjusting for length, salt, or nearest-neighbor stacking effects.
What to do instead
Use nearest-neighbor thermodynamic calculations with the salt and Mg2+ concentration stated for the reaction, and set annealing 3–5 °C below the lower primer Tm in the pair; when a question gives a Tm table, read the primer with the closest Tm to the annealing step rather than computing it.
Accepts a real-time PCR standard curve as valid because the slope looks close to −3.3, without recomputing efficiency or checking R-squared and replicate scatter across a full log-dilution series.
Textbook examples show a single tidy plot with slope −3.32 labelled 100% efficiency, so the number is memorized as a constant rather than derived from the data in front of them.
What to do instead
Compute efficiency directly (E = 10^(−1/slope) − 1) from at least three or four 10-fold dilutions run in duplicate, confirm R-squared of about 0.99 or better and replicate Cq spread of roughly 0.5 Cq or less, and treat a slope outside about −3.1 to −3.6 as a failed curve rather than a rounding difference.
Chooses or accepts a sodium heparin collection tube for a whole-blood molecular test such as a viral load or a BCR-ABL1 quantitative assay, then reports an inhibited or falsely low result.
Heparin is the default anticoagulant on many inpatient units and is present in the green-top tube most familiar from chemistry work, and candidates do not connect it to polymerase inhibition in the amplification step.
What to do instead
Specify EDTA (lavender-top) for whole-blood nucleic acid testing, recognize heparin as a PCR inhibitor that can also interfere with reverse transcriptase, and treat a heparin-contaminated specimen as a recollection rather than something to interpret around.
Concludes that an extracted nucleic acid sample is suitable for amplification because the A260/A280 ratio is around 1.8, without checking the 260/230 ratio or any amplification-based measure of integrity and inhibitor carryover.
A260/A280 is the purity metric drilled in during basic techniques and it is easy to treat one ratio as a complete quality assessment, but it is insensitive to residual guanidinium, ethanol, phenol, or fragmented nucleic acid.
What to do instead
Interpret 260/280 and 260/230 together, note that a high 260/280 with a depressed 260/230 signals chemical carryover, and confirm amplifiability with an internal or extraction control in the assay itself rather than relying on spectrophotometry alone.
Calls a specimen positive on the basis of a late-amplification signal (for example Cq above 38) without looking at whether the internal amplification control in that same reaction amplified normally.
Software flags any curve that crosses threshold and candidates fixate on the target channel, treating the internal control as a run-level formality rather than a per-well indicator of inhibition or low input.
What to do instead
Judge every target result against the internal control in the same well: a target signal accompanied by a failed or delayed internal control must be repeated or reported as inhibited, and late signals near the assay cutoff should be confirmed rather than reported as definitive positives.
Reads a Sanger sequencing electropherogram and calls a heterozygous insertion or deletion as a single point mutation at the first position where two peaks appear, ignoring the mixed sequence downstream.
The first abnormal position looks identical to a heterozygous single-nucleotide variant, and candidates stop reading at that peak instead of scanning the rest of the trace where the frameshift produces superimposed sequences.
What to do instead
After any position with two peaks, examine downstream bases: a true heterozygous substitution returns to clean single peaks, whereas a heterozygous indel shows two overlapping sequence patterns for every position beyond the breakpoint; confirm by re-sequencing the opposite strand or by fragment analysis.
Interprets a positive Chlamydia or gonorrhea NAAT collected two weeks after treatment as documented treatment failure and triggers retreatment or resistance workup.
Candidates reason that a nucleic acid test detects the organism, so a positive after therapy must mean the organism is still viable, forgetting that NAATs detect nonviable nucleic acid for weeks after effective treatment.
What to do instead
Do not use NAAT as a test of cure before the recommended window (generally about three to four weeks, and longer for some assays); interpret a positive result inside that window as residual nucleic acid and repeat testing only after the specified interval.
Classifies a novel missense variant as pathogenic because it is absent from population databases and several in silico predictors call it damaging.
Absence from gnomAD and a deleterious prediction feel decisive, and candidates apply individual ACMG criteria as if each one were sufficient, collapsing PM2 and PP3 into a pathogenic call.
What to do instead
Apply the ACMG/AMP combining rules: PM2 is supporting evidence only, PP3 is supporting and computational, and neither alone reaches pathogenic; without segregation, functional, or case-level evidence the correct report is a variant of uncertain significance with the criteria explicitly listed.
Continues a real-time PCR run and reports patient results when the no-template control shows a low-level amplification curve, on the grounds that the positive and negative patient controls behaved correctly.
The NTC is treated as a formality at the end of the checklist, and candidates assume control failures must occur in the patient-facing controls to be meaningful, missing that an NTC signal is the specific indicator of amplicon or reagent contamination.
What to do instead
Any amplification in the no-template control invalidates the run regardless of how the other controls performed; discard the results, decontaminate the work area and equipment, replace suspect reagents, and repeat the specimens only after the NTC is clean.
Performs reaction setup, amplification, and post-amplification analysis in the same room with the same pipettes, and does not use dUTP/UNG chemistry, in a laboratory running high-volume qualitative PCR.
Space and equipment constraints push small laboratories toward a single-bench workflow, and the contamination risk from aerosolized amplicon is invisible until unexplained low-level positives appear across unrelated specimens.
What to do instead
Maintain a unidirectional workflow with physically separated pre- and post-amplification areas, dedicated pipettes and lab coats for each, aliquot reagents once, and where the assay allows, incorporate dUTP with uracil-N-glycosylase so carried-over amplicon is destroyed before amplification.